Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FJ0PU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,469
Award facts
- Contract value 100% obligated
- $47,469.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,469.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 10, 2025, for the supply of Kisqali 600 mg daily dose tablets (63-count units). The contract is a non-set-aside competitive award with an ultimate completion date of April 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, supplying brand-name and generic medications to military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. Kisqali is a specialized oncology medication used in breast cancer treatment, reflecting the company's portfolio of specialty pharmaceuticals delivered to the Defense Health Agency and other federal healthcare systems. The firm fixed-price structure and rapid completion timeline are typical of delivery orders issued against established indefinite delivery contracts, which streamline procurement for recurring medical supply needs across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FJ0PU?
SPE2DB25FJ0PU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 10, 2025.
How much is contract SPE2DB25FJ0PU worth?
The government has obligated $47,469 on SPE2DB25FJ0PU.
Is contract SPE2DB25FJ0PU an order under another contract?
Yes. SPE2DB25FJ0PU is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ0PU competed?
The extent of competition for SPE2DB25FJ0PU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award